Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

Overall, biotech layoffs claimed at least 10,000 jobs within the sector last year, according to data compiled by BioPharma Dive. Many of those jobs were at smaller biotech companies more ...

After some years of a thriving life sciences job market, the Maryland biotech industry has had more than 1,200 layoffs in the last year, according to the State of Maryland’s Work Adjustment and ...

In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump compared to 2022, when 30 companies reported layoffs for the same period, according to a Fierce Biotech analysis. | In the ...

The biotech index fund XBI has climbed nearly 9% so far in 2023 and is up 11.74% over the last six months, trading at $88.80 per share. At its peak on Feb. 5, 2022, the XBI was trading at $166.78.

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from ...

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs by Charlotte Schubert on December 27, 2022 at 7:53 am Share 8 ...

In January, tech and biotech companies orchestrated the layoffs of 5,384 employees in Bay Area cities. In March, the projected layoff numbers currently total about 5,248.

Lately in the Boston life sciences industry, a Newton biotech cut 20% of its workforce, Novartis signed a deal with a Waltham ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

The biotech sector is off to a rocky start this year. After some signs of growth in late 2022, funding is down in 2023. Jefferies analysts said that if things don't improve, we'll see more layoffs ...